Skip to content
CharitiesAidWelfare, Medical Health Aged Care

MEDIA ALERT – PHOTO OPPORTUNITY

Bowel Cancer Australia < 1 mins read

MEDIA ALERT – PHOTO OPPORTUNITY

Youthfulness should not be a barrier to timely diagnosis

 

Where: Forecourt, Parliament House, Canberra

 

When: Tuesday, 20 June at 8.15am

 

What: 50 early-onset bowel cancer patients and medical experts

 

Australians from around the country impacted by early-onset bowel cancer along with medical experts will visit Parliament House to participate in Bowel Cancer Australia’s inaugural Call on Canberra to raise awareness and advocate for important policy change.

 

Latest Australian research reveals younger people with bowel cancer symptoms find self-advocating to be the only consistent and reliable resource for overcoming age bias, barriers to diagnosis, and optimising outcomes for the deadliest cancer in those aged 25-44.

 

  • 1-in-10 new bowel cancer cases are diagnosed in people under age 50 (1,680 annually).

 

  • Bowel cancer is the deadliest cancer for people aged 25-44.

 

  • Over the past three decades there has been a 266% increase in bowel cancer incidence rates in adolescents and young adults (15-24 years).

bowelcanceraustralia.org/early-onset


Contact details:


For an interview with a medical expert or patient contact:
Stephanie Bansemer-Brown – Bowel Cancer Australia
[email protected]   |   0412 915 797

Media

More from this category

  • Medical Health Aged Care
  • 18/12/2025
  • 22:11
BeOne Medicines Ltd.

BeOne Medicines Granted U.S. FDA Fast Track Designation for BGB-B2033 as Treatment for Hepatocellular Carcinoma

BGB-B2033 is a bispecific antibody directed at GPC3 and 4-1BB; key targets in the most common liver cancer FDA Fast Track Designation reflects the…

  • Contains:
  • Medical Health Aged Care
  • 18/12/2025
  • 19:11
Takeda Pharmaceutical Company Limited

Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment

Pivotal Phase 3 studies of once-daily oral zasocitinib met all primary and ranked secondary endpoints in patients with moderate-to-severe plaque psoriasis More than half…

  • Contains:
  • Medical Health Aged Care
  • 18/12/2025
  • 12:24
La Trobe University

Cell death discovery could aid cancer treatments

LaTrobe researchers have made a groundbreaking discovery about the way dying cells are cleared from our bodies, which could have important impacts on recovery from diseases including cancer infection and inflammatory diseases. Traditionally, it was believed dying cells were broken into smaller pieces by the cell’s own internal machinery, enabling the pieces to be more easily removed from the body. However the study, led by scientists at the La Trobe Institute for Molecular Science and Research Centre for Extracellular Vesicles found that the process of dying cell fragmentation is actually assisted by neighbouring cells. Published in Science Advances, the study…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.